S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
Log in
NYSE:ALB

Albemarle Stock Forecast, Price & News

$180.14
-2.23 (-1.22 %)
(As of 01/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$177.74
Now: $180.14
$183.78
50-Day Range
$131.72
MA: $150.23
$184.10
52-Week Range
$48.89
Now: $180.14
$187.25
Volume1.20 million shs
Average Volume2.18 million shs
Market Capitalization$19.18 billion
P/E Ratio50.32
Dividend Yield0.85%
Beta1.59
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. The company operates in three segments: Lithium, Bromine Specialties, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and value-added lithium specialties, as well as reagents, such as butyllithium and lithium aluminum hydride for applications in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes, life science, pharmaceutical, and other markets. It also offers cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for various pyrotechnical applications; technical services, such as the handling and use of reactive lithium products; and recycling services for lithium-containing by-products. The Bromine Specialties segment offers bromine and bromine-based solutions for fire safety, chemical synthesis, mercury control, water purification, beef and poultry processing, and other industrial applications, as well as oil and gas well drilling, and completion fluids applications; and tertiary amines, biocides, disinfectants, and sanitizers. The Catalysts segment offers hydroprocessing catalysts together with isomerization and akylation catalysts; fluidized catalytic cracking catalysts and additives; and performance catalyst solutions comprising organometallics and curatives. The company serves energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, crop protection, and custom chemistry services markets. Albemarle Corporation was founded in 1994 and is headquartered in Charlotte, North Carolina.
Albemarle logo

MarketRank

Overall MarketRank

2.07 out of 5 stars

Basic Materials Sector

32nd out of 652 stocks

Plastics Materials & Resins Industry

3rd out of 16 stocks

Analyst Opinion: 2.0Community Rank: 2.7Dividend Strength: 3.3Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Plastics materials & resins
Sub-IndustrySpecialty Chemicals
CUSIP01265310
Phone980-299-5700
Employees6,000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.59 billion
Cash Flow$8.08 per share
Book Value$38.61 per share

Profitability

Net Income$533.23 million

Miscellaneous

Market Cap$19.18 billion
Next Earnings Date2/17/2021 (Confirmed)
OptionableOptionable
$180.14
-2.23 (-1.22 %)
(As of 01/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ALB News and Ratings via Email

Sign-up to receive the latest news and ratings for ALB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Albemarle (NYSE:ALB) Frequently Asked Questions

How has Albemarle's stock been impacted by Coronavirus (COVID-19)?

Albemarle's stock was trading at $70.07 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ALB shares have increased by 157.1% and is now trading at $180.14.
View which stocks have been most impacted by COVID-19
.

Is Albemarle a buy right now?

23 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 6 sell ratings, 11 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Albemarle stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ALB, but not buy additional shares or sell existing shares.
View analyst ratings for Albemarle
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Albemarle?

Wall Street analysts have given Albemarle a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Albemarle wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Albemarle's next earnings date?

Albemarle is scheduled to release its next quarterly earnings announcement on Wednesday, February 17th 2021.
View our earnings forecast for Albemarle
.

How can I listen to Albemarle's earnings call?

Albemarle will be holding an earnings conference call on Wednesday, February 17th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Albemarle's earnings last quarter?

Albemarle Co. (NYSE:ALB) posted its quarterly earnings results on Monday, November, 9th. The specialty chemicals company reported $1.09 EPS for the quarter, topping the Zacks' consensus estimate of $0.78 by $0.31. The specialty chemicals company had revenue of $746.87 million for the quarter, compared to analyst estimates of $734.75 million. Albemarle had a net margin of 11.77% and a return on equity of 11.96%. The firm's revenue for the quarter was down 15.1% on a year-over-year basis. During the same quarter last year, the business posted $1.53 earnings per share.
View Albemarle's earnings history
.

How often does Albemarle pay dividends? What is the dividend yield for Albemarle?

Albemarle declared a quarterly dividend on Tuesday, October 27th. Shareholders of record on Friday, December 11th will be paid a dividend of $0.385 per share on Monday, January 4th. This represents a $1.54 annualized dividend and a yield of 0.85%. The ex-dividend date of this dividend is Thursday, December 10th.
View Albemarle's dividend history
.

Is Albemarle a good dividend stock?

Albemarle pays an annual dividend of $1.54 per share and currently has a dividend yield of 0.85%. Albemarle has been increasing its dividend for 27 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Albemarle is 25.50%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Albemarle will have a dividend payout ratio of 38.50% next year. This indicates that Albemarle will be able to sustain or increase its dividend.
View Albemarle's dividend history.

What guidance has Albemarle issued on next quarter's earnings?

Albemarle issued an update on its FY20 earnings guidance on Wednesday, November, 4th. The company provided earnings per share guidance of $3.80-4.15 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.48. The company issued revenue guidance of $3.05-3.15 billion, compared to the consensus revenue estimate of $3.04 billion.

What price target have analysts set for ALB?

23 analysts have issued 12 month target prices for Albemarle's shares. Their forecasts range from $50.00 to $175.00. On average, they anticipate Albemarle's stock price to reach $100.00 in the next year. This suggests that the stock has a possible downside of 44.5%.
View analysts' price targets for Albemarle
or view Wall Street analyst' top-rated stocks.

Are investors shorting Albemarle?

Albemarle saw a decrease in short interest during the month of December. As of December 31st, there was short interest totaling 4,420,000 shares, a decrease of 30.8% from the December 15th total of 6,390,000 shares. Based on an average daily volume of 1,230,000 shares, the short-interest ratio is currently 3.6 days.
View Albemarle's Short Interest
.

Who are some of Albemarle's key competitors?

What other stocks do shareholders of Albemarle own?

Who are Albemarle's key executives?

Albemarle's management team includes the following people:
  • Mr. Jerry Kent Masters Jr., Pres, CEO & Chairman (Age 60, Pay $150k)
  • Mr. Scott A. Tozier, Exec. VP & CFO (Age 55, Pay $974.29k)
  • Ms. Karen G. Narwold Esq., Exec. VP, Chief Admin. Officer, Gen. Counsel & Corp. Sec. (Age 61, Pay $861.02k)
  • Mr. Raphael Goszcz Crawford, Pres of Catalysts Global Bus. Unit (Age 45, Pay $1.01M)
  • Mr. Netha N. Johnson Jr., Pres of Bromine Specialties Global Bus. Unit (Age 50, Pay $1.51M)
  • Mr. John Clarence Barichivich III, VP, Corp. Controller & Chief Accounting Officer (Age 53)
  • Mr. Patrick Thompson, Chief Information Officer
  • Ms. Sharon B. McGee, VP of Corp. Devel. & Investor Relations
  • Ms. Melissa H. Anderson, Sr. VP & Chief HR Officer (Age 56)
  • Mr. Ahmad Khalifeh, Managing Director of Middle East Office

What is Albemarle's stock symbol?

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

Who are Albemarle's major shareholders?

Albemarle's stock is owned by many different retail and institutional investors. Top institutional investors include Scout Investments Inc. (0.19%), Axel Capital Management LLC (0.16%), Epiq Partners LLC (0.03%), Crossmark Global Holdings Inc. (0.02%), State of Alaska Department of Revenue (0.02%) and Guild Investment Management Inc. (0.01%). Company insiders that own Albemarle stock include Deeanne J Marlow, Eric Norris, Karen G Narwold, Luther C Iv Kissam, Raphael Goszcz Crawford and Scott Tozier.
View institutional ownership trends for Albemarle
.

Which institutional investors are selling Albemarle stock?

ALB stock was sold by a variety of institutional investors in the last quarter, including Guild Investment Management Inc., Scout Investments Inc., First Hawaiian Bank, State of Alaska Department of Revenue, Contravisory Investment Management Inc., Fulton Breakefield Broenniman LLC, Red Spruce Capital LLC, and Pinnacle Bank. Company insiders that have sold Albemarle company stock in the last year include Karen G Narwold, Luther C Iv Kissam, Raphael Goszcz Crawford, and Scott Tozier.
View insider buying and selling activity for Albemarle
or view top insider-selling stocks.

Which institutional investors are buying Albemarle stock?

ALB stock was bought by a variety of institutional investors in the last quarter, including Axel Capital Management LLC, Crossmark Global Holdings Inc., Engrave Wealth Partners LLC, Epiq Partners LLC, Redpoint Investment Management Pty Ltd, Radnor Capital Management LLC, IFM Investors Pty Ltd, and Charles Schwab Trust Co. Company insiders that have bought Albemarle stock in the last two years include Deeanne J Marlow, and Eric Norris.
View insider buying and selling activity for Albemarle
or or view top insider-buying stocks.

How do I buy shares of Albemarle?

Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Albemarle's stock price today?

One share of ALB stock can currently be purchased for approximately $180.14.

How big of a company is Albemarle?

Albemarle has a market capitalization of $19.18 billion and generates $3.59 billion in revenue each year. The specialty chemicals company earns $533.23 million in net income (profit) each year or $6.04 on an earnings per share basis. Albemarle employs 6,000 workers across the globe.

What is Albemarle's official website?

The official website for Albemarle is www.albemarle.com.

How can I contact Albemarle?

Albemarle's mailing address is 4250 CONGRESS STREET SUITE 900, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700 or via email at [email protected]

This page was last updated on 1/18/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.